PMID: 2866783Oct 1, 1985Paper

A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects

British Journal of Clinical Pharmacology
J W RigbyJ C Petrie


Six elderly patients with established hypertension and six young healthy subjects were studied after 8 days of treatment with atenolol 50 mg day-1, metoprolol 50 mg day-1, oxprenolol 80 mg day-1 and propranolol 80 mg day-1. The area under the blood concentration-time curve was increased in the elderly group for each drug, but the difference was statistically significant only for atenolol. The lower serum albumin concentrations in the elderly group did not result in a decrease in the percentage of propranolol or oxprenolol bound to serum proteins.


Aug 1, 1979·Clinical Pharmacology and Therapeutics·R E VestalD G Shand
Jun 1, 1975·The Journal of Pharmacy and Pharmacology·B Scales, P B Copsey
Jan 1, 1979·Drug Metabolism Reviews·W J Jusko
Jul 1, 1979·Clinical Pharmacology and Therapeutics·R E VestalG R Wilkinson
Nov 1, 1978·British Journal of Clinical Pharmacology·H E BarberJ M Swann
Jan 1, 1979·British Journal of Clinical Pharmacology·C M Castleden, C F George
Aug 1, 1975·British Journal of Clinical Pharmacology·C M CastledenR L Parsons
Aug 1, 1974·Journal of Pharmacokinetics and Biopharmaceutics·C G RegårdhL Palmer
Sep 26, 1973·Journal of Chromatography·E Di SalleP L Morselli
Jan 1, 1974·Clinical Pharmacology and Therapeutics·E J PantuckA H Conney
Sep 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·J D HarriesK N Drummond
Jan 1, 1982·European Journal of Clinical Pharmacology·F M BelpaireM Rosseneu
Jun 1, 1980·Clinical Pharmacology and Therapeutics·N DillonK O'Malley
Jan 1, 1983·European Journal of Clinical Pharmacology·C G RegårdhP O Lagerström
Feb 1, 1982·British Journal of Clinical Pharmacology·P C RubinJ L Reid
Mar 1, 1981·British Journal of Clinical Pharmacology·C P QuartermanD B Jack
Aug 1, 1980·British Journal of Clinical Pharmacology·R E SchneiderM J Kendall


Feb 1, 1992·Journal of Clinical Pharmacology·M Piquette-MillerF Jamali
Jan 1, 1993·European Journal of Clinical Pharmacology·T ShigaA Ebihara
Jan 1, 1986·European Journal of Clinical Pharmacology·I GretzerF Sjöqvist
Jan 1, 1982·European Journal of Clinical Pharmacology·D B JackM J Kendall
Feb 1, 1993·Mechanisms of Ageing and Development·F M BelpaireM G Bogaert
Jan 1, 1990·Pharmacology & Therapeutics·J McAinsh, J M Cruickshank
Nov 14, 2002·International Journal of Pharmaceutics·C L DobsonI R Wilding
Sep 8, 2010·Journal of Pharmaceutical Sciences·Emile G PliseLaurent Salphati
Dec 18, 2003·British Journal of Clinical Pharmacology·A A Mangoni, S H D Jackson
Apr 1, 1989·British Journal of Clinical Pharmacology·P ColangeloP McNamara
Mar 1, 2011·Journal of Pharmaceutical and Biomedical Analysis·Junting JiaJianping Liu
Jul 17, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Ingo StaudacherDierk Thomas
Apr 1, 1987·Drug Intelligence & Clinical Pharmacy·J O Covinsky
Jun 12, 2021·Critical Care : the Official Journal of the Critical Care Forum·Josée BouchardEXTRIP workgroup

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.